A Randomized Controlled Trial to Compare High-Flow Nasal Cannula with Nasal CPAP in Infants More Than 34 Weeks of Gestational Age with Respiratory Disorders

A Randomized Controlled Trial to Compare High-Flow Nasal Cannula with Nasal CPAP in Infants More Than 34 Weeks of Gestational Age with Respiratory Disorders - HFNC Versus NCPAP for Respiratory Disorders in Infants More Than 34 Gestational Weeks

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013907

Enrollment

260

Registered

2014-07-01

Start date

2015-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal respiratory disorders

Interventions

HFNC group NCPAP group NCPAP group

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: New born infants with respiratory disorders more than 34 weeks of gestational age

Exclusion criteria

Exclusion criteria: Chromosomal anomalies, Congenital anomalies

Design outcomes

Primary

Measure	Time frame
The incidence of intubation within 72 hours after starting to use each device	—

Countries

Japan

Contacts

Public ContactAtsushi Uchiyama

Tokai University School of Medicine Department of Pediatrics,

uchiyama.atsushi@tsc.u-tokai.ac.jp0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026